Agilent Upgrades Target-Enrichment Offering as Most Customers Choose Solution Method over Chips | GenomeWeb

By Justin Petrone

Agilent Technologies last week began offering its SureSelect Human All Exon 50 Mb Target Enrichment kit for next-generation DNA sequencing. The kit, developed together with researchers from the Wellcome Trust Sanger Institute, enables researchers to sequence the expressed genome while discarding regions that are not of interest.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.